메뉴 건너뛰기




Volumn 384, Issue 9959, 2014, Pages 2004-2006

Prostate cancer screening comes of age

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 84919843090     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61008-4     Document Type: Note
Times cited : (17)

References (12)
  • 1
    • 84856200634 scopus 로고    scopus 로고
    • Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: Mortality results after 13 years of follow-up
    • the PLCO Project Team
    • GL Andriole, ED Crawford, RL Grubb 3rd the PLCO Project Team Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up J Natl Cancer Inst 104 2012 125 132
    • (2012) J Natl Cancer Inst , vol.104 , pp. 125-132
    • Andriole, G.L.1    Crawford, E.D.2    Grubb Iii., R.L.3
  • 2
    • 63249118690 scopus 로고    scopus 로고
    • Screening and prostate-cancer mortality in a randomized European study
    • the ERSPC Investigators
    • FH Schroder, J Hugosson, MJ Roobol the ERSPC Investigators Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
    • (2009) N Engl J Med , vol.360 , pp. 1320-1328
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 3
    • 84919871373 scopus 로고    scopus 로고
    • Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
    • for the ERSPC Investigators published online Aug 7
    • FH Schroder, J Hugosson, MJ Roobol for the ERSPC Investigators Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up Lancet 2014 published online Aug 7. http://dx.doi.org/10.1016/S0140-6736(14)60525-0
    • (2014) Lancet
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 4
    • 77950519549 scopus 로고    scopus 로고
    • Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity
    • IJ Powell, CH Bock, JJ Ruterbusch, W Sakr Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity J Urol 183 2010 1792 1797
    • (2010) J Urol , vol.183 , pp. 1792-1797
    • Powell, I.J.1    Bock, C.H.2    Ruterbusch, J.J.3    Sakr, W.4
  • 5
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4·0 ng per milliliter
    • IM Thompson, DK Pauler, PJ Goodman et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4·0 ng per milliliter N Engl J Med 350 2004 2239 2246
    • (2004) N Engl J Med , vol.350 , pp. 2239-2246
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3
  • 6
    • 40949147326 scopus 로고    scopus 로고
    • Quality of life and satisfaction with outcome among prostate cancer survivors
    • MG Sanda, RL Dunn, J Michalski et al. Quality of life and satisfaction with outcome among prostate cancer survivors N Engl J Med 358 2008 1250 1261
    • (2008) N Engl J Med , vol.358 , pp. 1250-1261
    • Sanda, M.G.1    Dunn, R.L.2    Michalski, J.3
  • 7
    • 73949130115 scopus 로고    scopus 로고
    • Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    • L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
    • (2010) J Clin Oncol , vol.28 , pp. 126-131
    • Klotz, L.1    Zhang, L.2    Lam, A.3    Nam, R.4    Mamedov, A.5    Loblaw, A.6
  • 8
    • 33751018522 scopus 로고    scopus 로고
    • Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial
    • IM Thompson, CM Tangen, J Paradelo et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
    • (2006) JAMA , vol.296 , pp. 2329-2335
    • Thompson, I.M.1    Tangen, C.M.2    Paradelo, J.3
  • 9
    • 39149085396 scopus 로고    scopus 로고
    • Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610
    • M Roach 3rd, K Bae, J Speight et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610 J Clin Oncol 26 2008 585 591
    • (2008) J Clin Oncol , vol.26 , pp. 585-591
    • Roach Iii., M.1    Bae, K.2    Speight, J.3
  • 10
    • 38349164176 scopus 로고    scopus 로고
    • Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial
    • AV D'Amico, MH Chen, AA Renshaw, M Loffredo, PW Kantoff Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial JAMA 299 2008 289 295
    • (2008) JAMA , vol.299 , pp. 289-295
    • D'Amico, A.V.1    Chen, M.H.2    Renshaw, A.A.3    Loffredo, M.4    Kantoff, P.W.5
  • 11
    • 84864008031 scopus 로고    scopus 로고
    • Radical prostatectomy versus observation for localized prostate cancer
    • for the Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group
    • TJ Wilt, MK Brawer, KM Jones for the Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
    • (2012) N Engl J Med , vol.367 , pp. 203-213
    • Wilt, T.J.1    Brawer, M.K.2    Jones, K.M.3
  • 12
    • 33646459214 scopus 로고    scopus 로고
    • Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial
    • IM Thompson, DP Ankerst, C Chi et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534
    • (2006) J Natl Cancer Inst , vol.98 , pp. 529-534
    • Thompson, I.M.1    Ankerst, D.P.2    Chi, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.